#4 - Danaher (NYSE:DHR)
The next company on this list is also not a pure play water company. Danaher (NYSE:DHR) is a diverse industrial conglomerate. However, one of the company’s revenue drivers comes from providing water testing equipment.
This helps solve the problem of the nearly 33% of the global population that lacks access to clean drinking water. It also gives the company a large addressable market. And by some accounts, that segment accounts for nearly 10% of the company’s revenue which continues to climb on both a sequential and annual basis. For the next five years, the company’s revenue and earnings are both expected to climb at around 5%. But if water is the driver that it’s expected to be the company’s revenue may approach its historical 12% annual revenue gains.
DHR stock is down approximately 15% this year which puts it in line with the S&P 500. However, Danaher maintains a Moderate Buy rating from the analysts tracked by MarketBeat. Those same analysts give DHR stock a price target of $324 which is about a 16% upside from current levels.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More - Current Price
- $258.68
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 9 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $267.31 (3.3% Upside)
